Загрузка...
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
Radical cure of Plasmodium vivax malaria in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals employs weekly primaquine dosing. This is the only recommended regimen for this patient sub-group. If national malaria programs mandate daily primaquine dosing (the recommended regimen for G6PD...
Сохранить в:
| Опубликовано в: : | Wellcome Open Res |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
F1000 Research Limited
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6480970/ https://ncbi.nlm.nih.gov/pubmed/31069260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.15100.2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|